Obesity in survivors of childhood acute lymphoblastic leukemia and lymphoma.

Autor: Razzouk BI, Rose SR, Hongeng S, Wallace D, Smeltzer MP, Zacher M, Pui CH, Hudson MM

Publikováno v: Journal of Clinical Oncology; 4/1/2007, Vol. 25 Issue 10, p1183-1189, 7p

Cardiotoxicity of CPX-351 in children and adolescents with relapsed AML: a Children's Oncology Group report.

Autor: Leger KJ; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States., Absalon MJ; Department of Pediatrics, Oregon Health Sciences University, Portland, OR, United States., Demissei BG; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Smith AM; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Gerbing RB; Children's Oncology Group, Monrovia, CA, United States., Alonzo TA; Children's Oncology Group, Monrovia, CA, United States.; Department of Population and Public Health Sciences, University of Southern California, Los Angeles, CA, United States., Narayan HK; Department of Pediatrics, University of California San Diego, Rady Children's Hospital San Diego, La Jolla, CA, United States., Hirsch BA; Department of Pediatrics, University of Minnesota, Minneapolis, MN, United States., Pollard JA; Division of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Pediatrics, Harvard Medical School, Boston, MA, United States., Razzouk BI; Department of Pediatrics, Peyton Manning Children's Hospital at Ascension St. Vincent, Indianapolis, IN, United States., Getz KD; Departments of Biostatistics, Epidemiology & Informatics and Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States., Aplenc R; Division of Oncology, The Children's Hospital of Philadelphia, Philadelphia, PA, United States., Kolb EA; Nemours Center for Cancer and Blood Disorders, A.I. DuPont Hospital for Children, Wilmington, DE, United States., Ky B; Division of Cardiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States., Cooper TM; Division of Pediatric Hematology/Oncology, Seattle Children's Hospital, University of Washington, Seattle, WA, United States.

Publikováno v: Frontiers in cardiovascular medicine [Front Cardiovasc Med] 2024 Jun 14; Vol. 11, pp. 1347547. Date of Electronic Publication: 2024 Jun 14 (Print Publication: 2024).

Phase I/II Study of CPX-351 Followed by Fludarabine, Cytarabine, and Granulocyte-Colony Stimulating Factor for Children With Relapsed Acute Myeloid Leukemia: A Report From the Children's Oncology Group.

Autor: Cooper TM; Department of Hematology/Oncology, Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA., Absalon MJ; Cincinnati Children's Hospital Medical Center, Cincinnati, OH., Alonzo TA; Department of Preventive Medicine, University of Southern California, Los Angeles, CA., Gerbing RB; Children's Oncology Group, Monrovia, CA., Leger KJ; Department of Hematology/Oncology, Cancer and Blood Disorders Center, Seattle Children's Hospital, Seattle, WA., Hirsch BA; University of Minnesota, Minneapolis, MN., Pollard J; Dana-Farber Cancer Institute/Boston Children's Hospital, Boston, MA., Razzouk BI; Peyton Manning Children's Hospital at St Vincent, Indianapolis, IN., Aplenc R; Children's Hospital of Philadelphia, Philadelphia, PA., Kolb EA; Nemours Center for Cancer and Blood Disorders/Alfred I. DuPont Hospital for Children, Wilmington, DE.

Publikováno v: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2020 Jul 01; Vol. 38 (19), pp. 2170-2177. Date of Electronic Publication: 2020 May 13.

Phase I/II trial of clofarabine and cytarabine in children with relapsed/refractory acute lymphoblastic leukemia (AAML0523): a report from the Children's Oncology Group.

Autor: Cooper TM; Aflac Cancer and Blood Disorders Center/Children's Healthcare of Atlanta/Emory University, Atlanta, Georgia 30322, USA. todd.cooper@choa.org, Razzouk BI, Gerbing R, Alonzo TA, Adlard K, Raetz E, Gamis AS, Perentesis J, Whitlock JA

Publikováno v: Pediatric blood & cancer [Pediatr Blood Cancer] 2013 Jul; Vol. 60 (7), pp. 1141-7. Date of Electronic Publication: 2013 Jan 17.

Randomized trial of 2 dosages of prophylactic granulocyte-colony-stimulating factor after induction chemotherapy in pediatric acute myeloid leukemia.

Autor: Inaba H; Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee 38105, USA. hiroto.inaba@stjude.org, Cao X, Pounds S, Pui CH, Rubnitz JE, Ribeiro RC, Razzouk BI

Publikováno v: Cancer [Cancer] 2011 Mar 15; Vol. 117 (6), pp. 1313-20. Date of Electronic Publication: 2010 Nov 08.